ARCHIVES

New Government-Wide Regulatory Policy Set For Carcinogens; Industry Group Says They are Not Scientific

This article is from The Cancer Letter archive.

Vol. 05 No. 40 | October 5, 1979

Download PDF Visit The Full Archive

Related Articles

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

December 1, 2000

Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2

April 17, 1987

Bush Keeps Klausner As NCI Director; Senate Confirms Thompson For HHS.

January 26, 2001

Contract Awards Sole Source Negotiations

January 13, 1978

Bypass Budget Will Call For 15-percent Increase

February 18, 2011

USPSTF Recommends Hepatitis C Screening For Baby Boomers

June 26, 2013